摘要
目的探讨部分脾栓塞在肝癌合并脾亢患者介入治疗中的应用效果。方法回顾性分析本院38例肝癌合并脾亢患者的临床资料,所有患者均采取部分脾栓塞介入治疗,观察栓塞前后血细胞数量。结果本组38例肝癌合并脾亢患者经治后,白细胞计数和血小板计数均较治疗前有显著升高,差异有统计学意义(P<0.05)。术后3例患者出现腹水,2例患者出现胸腔积液,经对症处理后症状缓解。结论采用部分脾栓塞介入治疗肝癌合并脾亢临床疗效好,手术创伤小,术后并发症较少,是一种安全有效的治疗方式,值得临床进一步推广使用。
Objective To investigate the effect of partial splenic embolization interventional treatment in liver cancer combined hypersplenism. Methods A retrospective analysis about the clinical data of 38 cases of liver cancer combined hypersplenism in our hospital was operated,all patients were treated by partial splenic embolization interventional therapy,observed blood cell count before and after embolization. Results After treatment,the white cell count and platelet count were significantly increased than before,the difference was statistically significant (P0.05) . 3 cases occured ascites,2 cases occured pleural effusion after treatment,all relieved after symptomatic treatment. Conclusion Taking partial splenic embolization interventional treat-ment to liver cancer combined hypersplenism has good effect,and operation has little trauma,less postoperative complications,it is a safe and effective treatment,worthy of further clinical application.
出处
《中国实用医药》
2013年第18期36-37,共2页
China Practical Medicine
关键词
肝癌
脾亢
部分脾栓塞
介入
Liver cancer
Hypersplenism
Partial splenic embolization
Interventional